- Home
- NUVB vs NBBK Comparison
NUVB vs NBBK Comparison
Compare NUVB & NBBK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NUVB
- NBBK
- Stock Information
- Founded
- NUVB 2018
- NBBK 1892
- Country
- NUVB United States
- NBBK United States
- Employees
- NUVB N/A
- NBBK N/A
- Industry
- NUVB Biotechnology: Pharmaceutical Preparations
- NBBK
- Sector
- NUVB Health Care
- NBBK
- Exchange
- NUVB Nasdaq
- NBBK Nasdaq
- Market Cap
- NUVB 679.9M
- NBBK 661.3M
- IPO Year
- NUVB N/A
- NBBK N/A
- Fundamental
- Price
- NUVB $2.10
- NBBK $17.43
- Analyst Decision
- NUVB Strong Buy
- NBBK Buy
- Analyst Count
- NUVB 5
- NBBK 1
- Target Price
- NUVB $8.20
- NBBK $22.00
- AVG Volume (30 Days)
- NUVB 3.2M
- NBBK 172.2K
- Earning Date
- NUVB 05-07-2025
- NBBK 04-22-2025
- Dividend Yield
- NUVB N/A
- NBBK N/A
- EPS Growth
- NUVB N/A
- NBBK 421.39
- EPS
- NUVB N/A
- NBBK 1.18
- Revenue
- NUVB $10,957,000.00
- NBBK $169,131,000.00
- Revenue This Year
- NUVB $75.73
- NBBK N/A
- Revenue Next Year
- NUVB $440.21
- NBBK N/A
- P/E Ratio
- NUVB N/A
- NBBK $14.84
- Revenue Growth
- NUVB N/A
- NBBK 25.80
- 52 Week Low
- NUVB $1.54
- NBBK $14.20
- 52 Week High
- NUVB $3.97
- NBBK $21.05
- Technical
- Relative Strength Index (RSI)
- NUVB 50.80
- NBBK 52.80
- Support Level
- NUVB $1.98
- NBBK $17.08
- Resistance Level
- NUVB $2.30
- NBBK $17.82
- Average True Range (ATR)
- NUVB 0.16
- NBBK 0.43
- MACD
- NUVB -0.01
- NBBK 0.13
- Stochastic Oscillator
- NUVB 21.43
- NBBK 73.83
About NUVB Nuvation Bio Inc.
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's clinical-stage product candidate is NUV-868, a BD2-selective oral small molecule BET inhibitor. NUV-868 inhibits the protein BRD4, a key member of the BET family that epigenetically regulates a number of important proteins that control tumor growth and differentiation, including oncogenes such as c-myc. Notably, BET proteins have critical biological functions and are found to be altered in many human cancers. It is also developing its proprietary, small molecule Drug-Drug Conjugate (DDC) platform, a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies with parallels to Antibody-Drug Conjugates (ADCs).
About NBBK NB Bancorp Inc.
NB Bancorp Inc operates as the holding company of Needham Bank. Its business consists of taking deposits from the general public and investing those deposits, together with funds generated from operations, in commercial real estate and multifamily loans, one- to four-family residential real estate loans, construction and land development loans, commercial and industrial loans, and consumer loans.